Terms of
Clearance: This collection is approved under the following terms of
clearance: Upon publishing a new 60-day and 30-day Federal Register
Notice, CMS will provide the public and OMB with a supplemental
document that crosswalks all changes (technical and substantive)
made to the revised ICR. The document should include an explanation
of each change from the previous approval, the reason why the
change is necessary and the citation or reference to the statute,
regulation or guidance document that support the need for the
change. The crosswalk should also address an increase or decrease
in burden for each change.
Inventory as of this Action
Requested
Previously Approved
03/31/2011
36 Months From Approved
12/31/2010
6,050
0
6,050
42,350
0
42,350
0
0
0
Under the Medicare Prescription Drug,
Improvement, and Modernization Act of 2003 (MMA), and implementing
regulations at 42 CFR, Medicare Advantage organizations (MAO) and
Prescription Drug Plans (PDP) are required to submit an actuarial
pricing "bid" for each plan offered to Medicare beneficiaries for
approval by the Centers for Medicare & Medicaid Services (CMS).
MAOs and PDPs use the Bid Pricing Tool (BPT) software to develop
their actuarial pricing bid. The information provided in the BPT is
the basis for the plan's enrollee premiums and CMS payments for
each contract year.
US Code:
42
USC 1395w-24 Name of Law: SUBMISSION OF PROPOSED PREMIUMS, BID
AMOUNTS, AND RELATED INFORMATION
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.